INTERPACE BIOSCIENCES, INC. Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases
INTERPACE BIOSCIENCES, INC. (IDXG) reported Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases of $4.40 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-30.
Financial Statements › Notes › Fair Value Disclosures › Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation
us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases · last filed 2026-03-30
- INTERPACE BIOSCIENCES, INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, purchases for the quarter ending 2025-12-31 was $1.00M, a 49.67% decline year-over-year.
- INTERPACE BIOSCIENCES, INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, purchases for the quarter ending 2025-09-30 was $900.00K, a 40.00% decline year-over-year.
- INTERPACE BIOSCIENCES, INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, purchases for the quarter ending 2025-06-30 was $1.00M, a 50.00% decline year-over-year.
- INTERPACE BIOSCIENCES, INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, purchases for the quarter ending 2025-03-31 was $1.50M, a 150.00% increase year-over-year.
- INTERPACE BIOSCIENCES, INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, purchases for fiscal 2025 was $4.40M, a 27.71% decline from fiscal 2024.
- INTERPACE BIOSCIENCES, INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, purchases for fiscal 2024 was $6.09M, a 143.48% increase from fiscal 2023.
- INTERPACE BIOSCIENCES, INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, purchases for fiscal 2023 was $2.50M.
| Period end | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases 3 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases 6 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases 9 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases 12 month |
|---|---|---|---|---|
| 2025-12-31 | $1.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $1.90M derived: sum of 2 quarters · filed 2026-03-30 | $2.90M derived: sum of 3 quarters · filed 2026-03-30 | $4.40M 10-K · filed 2026-03-30 |
| 2025-09-30 | $900.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $1.90M derived: sum of 2 quarters · filed 2025-11-12 | $3.40M 10-Q · filed 2025-11-12 | $5.39M derived: sum of 4 quarters · filed 2025-11-12 |
| 2025-06-30 | $1.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $2.50M 10-Q · filed 2025-08-07 | $4.49M derived: sum of 3 quarters · filed 2025-08-07 | $5.99M derived: sum of 4 quarters · filed 2025-08-07 |
| 2025-03-31 | $1.50M 10-Q · filed 2025-05-08 | $3.49M derived: sum of 2 quarters · filed 2025-05-08 | $4.99M derived: sum of 3 quarters · filed 2025-05-08 | $6.99M derived: sum of 4 quarters · filed 2025-05-08 |
| 2024-12-31 | $1.99M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $3.49M derived: sum of 2 quarters · filed 2025-03-31 | $5.49M derived: sum of 3 quarters · filed 2025-03-31 | $6.09M 10-K · filed 2025-03-31 |
| 2024-09-30 | $1.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | $3.50M derived: sum of 2 quarters · filed 2024-11-08 | $4.10M 10-Q · filed 2024-11-08 | |
| 2024-06-30 | $2.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $2.60M 10-Q · filed 2024-08-08 | ||
| 2024-03-31 | $600.00K 10-Q · filed 2024-05-09 | |||
| 2023-12-31 | $2.50M 10-K · filed 2024-04-01 |